Back to search

Article

Preliminary Study on The Relationship of BRAF Mutations to The Outcome of The First 131I Radiotherapy and Malignant Biological Characteristics in Papillary Thyroid Carcinoma

2021-06-29

Abstract excerpt

<title>Abstract</title> <p><bold><italic>Objective</italic></bold><italic> </italic>To investigate the relationship of <italic>BRAF </italic>mutation to the outcome of the first postoperative <sup>131</sup>I treatment and malignant biological characteristics in papillary thyroid carcinoma (PTC) and the clinical value of circulating tumor DNA (ctDNA). <bold><italic>Methods</italic> </bold>Thirty-three patients wit...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f85b8401-0593-5967-881c-697001a7a0ad
DOI
10.21203/rs.3.rs-651293/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Preliminary Study on The Relationship of BRAF Mutations to The Outcome of The First 131I Radiotherapy and Malignant Biological Characteristics in Papillary Thyroid CarcinomaDOI 10.21203/rs.3.rs-651293/v1
The BRAF V600E mutation is a predictor of the effect of radioiodine therapy in papillary thyroid cancerSemantic proximity
Clinical significance of the BRAFV600E mutation in PTC and its effect on radioiodine therapySemantic proximity
BRAF V600E mutation in papillary thyroid cancer and its effect on postoperative radioiodine (131I) therapy: Should we modify our therapeutic strategy?Semantic proximity
The role of BRAF V600E mutation in post-surgical 131I therapy in papillary thyroid carcinoma: a study based on SPECT-CT uptake analysis.Semantic proximity
Circulating Tumor DNA Harboring the BRAFV600E Mutation May Predict Poor Outcomes of Primary Papillary Thyroid Cancer Patients.Semantic proximity
Noninferior response in BRAF(V600E) mutant nonmetastatic papillary thyroid carcinoma to radioiodine therapy.Semantic proximity
[Clinical, morphological, and prognostic features of papillary thyroid carcinoma with different BRAF mutational status assessed by immunohistochemistry].Semantic proximity
BRAFV600E Mutation Associated With Non–Radioiodine-Avid Status in Distant Metastatic Papillary Thyroid CarcinomaSemantic proximity
FDG PET/CT imaging in recurrent papillary thyroid cancer: does BRAF mutation status matter?Semantic proximity
Can we safely reduce the administration of 131-iodine in patients with differentiated thyroid cancer? – experience of the Brugmann hospital in BrusselsSemantic proximity
The presence of <i>BRAF</i> point mutation in adult papillary thyroid carcinomas from atomic bomb survivors correlates with radiation doseSemantic proximity
Risk of second primary malignancies following radioactive iodine therapy in thyroid cancer: A meta-analysis of 1,189,992 patientsSemantic proximity
Select a neighboring publication to make it the new centre.